Global Cannabinoid Solutions (GCS) is proud to announce the public release of the UK’s first Endocannabinoid System (ECS) Induction Program — a landmark step in making cannabinoid science accessible to all.

Originally developed for our medical partners, this program has now been declassified as part of our ongoing mission to transform the cannabis sector through digital science and open access to knowledge.

The ECS — the body’s hidden regulatory system controlling pain, mood, sleep, and appetite — lies at the heart of cannabinoid medicine. Yet, it remains one of the least understood systems in modern healthcare. Our new digital induction bridges that gap, translating decades of research into practical understanding for professionals, patients, and innovators alike.

Led by GCS Founder & CEO, Chris Tasker, this training marks a pivotal moment for scientific literacy in cannabis, giving every learner the foundation to engage confidently with cannabinoid-based therapeutics.

“Our goal has always been to democratize cannabinoid science. By digitizing our medical programs, we’re putting the best research directly into the hands of those shaping the future of this industry,” says Dr. Tasker.

The ECS Induction Program is now available through CannabisScienceTraining.com, continuing GCS’s mission to empower innovation through Scientific Cannabis Intelligence (SCI).

🌿 Discover the science that changes everything.
👉 Access the ECS Induction Program Now